How is fibroid treatment chosen?
Treatment choice sits at the intersection of five factors: the type and severity of your symptoms, the fibroid’s location (type), its size and number, your pregnancy plans, and your personal priorities. The same fibroid can lead to two different right answers in two different patients — which is why the decision is always individual.
The options compared
| Aspect | Monitoring | Medication | Myomectomy | Hysterectomy | UFE | HIFU |
|---|---|---|---|---|---|---|
| Intervention | None | None | Surgery | Surgery | Endovascular | External |
| Uterus | Preserved | Preserved | Preserved | Not preserved | Preserved | Preserved |
| Anaesthesia | — | — | General | General | Local/sedation | Sedation |
| Hospital stay | — | — | Yes | Yes | Short | Short/day-case |
| Durations vary by technique and centre. | ||||||
| Fibroid tissue | Remains | Remains | Removed | Removed with uterus | Shrinks | Shrinks |
| Fertility evidence | — | Symptom bridge | Established | Pregnancy ends | Nuanced | Conflicting data |
| With pregnancy plans, method choice needs particular care — details on the linked pages. | ||||||
| Retreatment likelihood | — | Symptoms can return after stopping | Low; new fibroids possible | None | Moderate | Selection-dependent; higher than surgery on average |
| Reintervention differs across uterus-preserving methods; patient selection is decisive. | ||||||
Comparative meta-analyses show reintervention rates differing across uterus-preserving methods, while less invasive methods associate with shorter hospital stay and faster recovery.
The table shows general profiles; what they mean in your case is determined by individual assessment.
Source: 2021 · International Journal of Hyperthermia2021 · Frontiers in Oncology
Thinking in scenarios
Bleeding dominates and the cavity is involved
Evaluation of the cavity usually comes first; with a submucosal component, hysteroscopic options and cavity-directed approaches move forward, with medication often bridging symptoms.
Pregnancy is the priority
Myomectomy is the established option when fertility comes first; data for non-surgical methods are still maturing. Here the decision deserves open discussion of the evidence, and where needed, reproductive medicine input.
Pressure symptoms dominate and surgery is not wanted
Uterus-preserving, less invasive options — embolisation, and HIFU in suitable cases — are frequently assessed in this profile; imaging determines which is technically feasible.
Close to menopause
If symptoms are manageable, monitoring plus symptom control can be a legitimate strategy given the natural shrinkage expected with menopause.
Clarify your own table
With your imaging, we can discuss your options over your own case.
Request a specialist assessment